Business Context and Reporting Period
Mink Therapeutics, Inc. (INKT) filed a Current Report on Form 8-K on January 17, 2025. The company is an emerging growth company incorporated in Delaware with principal executive offices in New York. The report details a Special Meeting of Stockholders held on January 17, 2025, to approve a corporate restructuring action.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes; it does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes
The primary material change reported is the approval of a 1-for-10 reverse stock split of the Company's issued and outstanding common stock. Key details include:
- Effective Date: The reverse stock split will be effective at 12:01 a.m., Eastern Time, on January 28, 2025.
- Trading Impact: Common stock is expected to begin trading on a post-split basis on January 28, 2025, under CUSIP number 603693 201.
- Share Count: As of the Record Date (December 16, 2024), there were 39,630,402 shares outstanding.
Guidance, Outlook, and Voting Results
The filing does not contain forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the procedural details of the stock split. The voting results for the Special Meeting were as follows:
- Proposal 1 (Reverse Stock Split): Approved.
- Votes For: 26,500,274
- Votes Against: 1,026,255
- Abstentions: 56,013
- Quorum: 27,582,512 shares were present or represented by proxy, constituting a quorum.
Investor Verification Checklist
- Verify the effective date of the 1-for-10 reverse stock split (January 28, 2025).
- Confirm the new CUSIP number (603693 201) for post-split trading.
- Review the company's most recent 10-K or 10-Q filings for financial health metrics, as this 8-K contains no financial data.
- Monitor trading volume and price adjustments on January 28, 2025, to ensure proper market implementation of the split.